BIOL
Biolase, Inc.
BIOL
BIOL
Delisted
BIOL was delisted on the 18th of June, 2024.
18 hedge funds and large institutions have $8.65M invested in Biolase, Inc. in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Holders
18
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$37.7K | |
| 2 | +$18.8K | |
| 3 | +$15.1K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.77K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$3.77K |
Top Sellers
| 1 | -$185K | |
| 2 | -$152K | |
| 3 | -$94.2K | |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
-$38K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16K |